Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Percutaneous coronary intervention Stories

2013-10-28 08:29:42

Agreement expands Philips' interventional cardiology portfolio ANDOVER AND BURLINGTON, Mass., Oct. 28, 2013 /PRNewswire/ -- Royal Philips (NYSE: PHG; AEX: PHIA) and Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery disease today announced a non-exclusive resale agreement for Infraredx's TVC Imaging System. Under the terms of the agreement, Philips will sell Infraredx's TVC Imaging System alongside its Allura...

2013-10-28 08:28:49

- Demonstrated Lack of Late Lumen Loss Progression Over 18 Months in Conjunction with Excellent Tissue Healing - DURHAM, N.C., Oct. 28, 2013 /PRNewswire/ -- Micell Technologies, Inc. today announced that imaging and clinical results from the DESSOLVE I and DESSOLVE II trials of its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES(®)) were presented at the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference held in San...

2013-10-15 16:26:12

Angioplasty and bypass surgery can lead to similar longterm benefits, finds study led by Saint Luke's Mid America Heart Institute researchers published in Journal of the American Medical Association KANSAS CITY, Mo., Oct. 15, 2013 /PRNewswire-USNewswire/ -- For patients with diabetes and coronary artery disease in more than one artery, treatment with coronary artery bypass graft (CABG) surgery provided slightly better health status and quality of life between six months and two...

2013-10-14 11:00:12

Psychological interventions halve deaths and cardiovascular events in heart disease patients, according to research from Athens, Greece, presented at the Acute Cardiac Care Congress 2013. The Acute Cardiac Care Congress 2013 is the annual meeting of the Acute Cardiovascular Care Association (ACCA) of the European Society of Cardiology (ESC). It takes place 12-14 October in Madrid, Spain. Dr Zoi Aggelopoulou, a nurse and one of the study authors, said: "The nurses on our coronary care...

2013-10-02 08:29:35

BASKING RIDGE, N.J., Oct. 2, 2013 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced it will present at the Biotechnology Industry Organization's 12(th) Annual BIO Investor Forum, to be held October 8-9, 2013, at the Palace Hotel in San Francisco. BIO Investor Forum is a national investor forum to explore...

2013-09-30 08:29:06

-- TCT 2013 presentation of data planned -- DURHAM, N.C., Sept. 30, 2013 /PRNewswire/ -- Micell Technologies, Inc. today announced that a peer reviewed article discussing imaging and clinical results of the DESSOLVE I trial of its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES(®)) was accepted for publication on the JACC Cardiovascular Interventions website. The paper, "First-in-Human Evaluation of a Bioabsorbable Polymer-Coated Sirolimus-Eluting...

2013-09-25 08:29:46

BASKING RIDGE, N.J., Sept. 25, 2013 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced it will present at the Aegis Capital Vegas Healthcare Conference, to be held September 25 - 28, 2013, at the Encore at Wynn Las Vegas. David J. Mazzo, Ph.D., President and Chief Executive Officer of Regado Biosciences, will...

2013-09-19 13:19:57

Cardiologists are increasingly accessing coronary arteries by way of the wrist rather than the groin to insert life-saving stents into patients with blocked arteries, according to the first broad report of the American College of Cardiology's clinical data registries published online today in the Journal of the American College of Cardiology. The report, "Cardiovascular Care Facts: A Report from the National Cardiovascular Data Registry - 2011," includes data about stents from the CathPCI...

2013-09-18 23:19:05

Founder, researcher, patent holder Pax Beale, through the nonprofit BodyForTheAges.Org announces its Prescription Method of Training for heart rehabilitation, available exclusively through the web. It’s a multi-step program that includes a specific weight-resistance training regime, as opposed to aerobics, and it’s a rival to medical angioplasty, in some instances. San Francisco, CA (PRWEB) September 18, 2013 Ex-heart cripple/researcher Pax Beale pioneered weight-resistance training...

2013-09-17 08:30:47

"REGULATE-PCI" to Study REG1 in Patients Undergoing Percutaneous Coronary Intervention BASKING RIDGE, N.J., Sept. 17, 2013 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications, today announced the enrollment of the first patient in its REGULATE-PCI clinical trial. REGULATE-PCI is a...


Latest Percutaneous coronary intervention Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »